个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Exploring the most appropriate primary endpoint of immune checkpoint inhibitors for previously treated advanced solid cancers

| 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Zhu, Jie[1,2,3,4] ; Li, Jingqiu[1,2,3,4] ; Zhou, Xiaoding[1,2,3,4] ; Gao, Binyang[1,2,3,4] ; Zhang, Hanlin[1,2,3,4] ; Wu, Lei[1,2,3,4] ; Wang, Yi[1,2,3,4] ; Ma, Jiabao[1,2,3,4] ; Tan, Yan[1,2,3,4] ; Lang, Jin Yi[1,2,3,4] ; Wang, Qifeng[1,2,3,4] ;
机构： [1]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu 610042, Peoples R China [2]Sichuan Univ, Dept Ultrasound, West China Hosp, Chengdu, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Dept Dermatol, Peking Union Med Coll Hosp, Beijing, Peoples R China [4]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu, Peoples R China
出处：
ISSN：
基金：
Science and Technology Department of Sichuan Province [2019YFS0378]
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2023]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu 610042, Peoples R China [2]Sichuan Univ, Dept Ultrasound, West China Hosp, Chengdu, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Dept Dermatol, Peking Union Med Coll Hosp, Beijing, Peoples R China [4]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu, Peoples R China
通讯作者：
通讯机构： [1]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu 610042, Peoples R China [2]Sichuan Univ, Dept Ultrasound, West China Hosp, Chengdu, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Dept Dermatol, Peking Union Med Coll Hosp, Beijing, Peoples R China [4]Univ Elect Sci & Technol China, Dept Radiat Oncol, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr,Sichuan Canc Hosp & Inst,Sch Med, Chengdu, Peoples R China
推荐引用方式(GB/T 7714)：
Zhu Jie,Li Jingqiu,Zhou Xiaoding,et al.Exploring the most appropriate primary endpoint of immune checkpoint inhibitors for previously treated advanced solid cancers[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41(16):
APA：
Zhu, Jie,Li, Jingqiu,Zhou, Xiaoding,Gao, Binyang,Zhang, Hanlin...&Wang, Qifeng.(2023).Exploring the most appropriate primary endpoint of immune checkpoint inhibitors for previously treated advanced solid cancers.JOURNAL OF CLINICAL ONCOLOGY,41,(16)
MLA：
Zhu, Jie,et al."Exploring the most appropriate primary endpoint of immune checkpoint inhibitors for previously treated advanced solid cancers".JOURNAL OF CLINICAL ONCOLOGY 41..16(2023)

资源点击量：43378 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号